Old Web
English
Sign In
Acemap
>
Paper
>
469PHighly selective c-Met inhibitor tepotinib plus gefitinib is active in Asian patients with c-Met+ NSCLC
469PHighly selective c-Met inhibitor tepotinib plus gefitinib is active in Asian patients with c-Met+ NSCLC
2015
Ross A. Soo
Dong Wook Kim
J.C. Yang
K. Park
U. Stammberger
H. Xiong
C. Ihling
Y. Wu
Keywords:
c-Met inhibitor
General surgery
C-Met
Gefitinib
Medicine
Oncology
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
5
Citations
NaN
KQI
[]